Abiopharma

🔍 GLENN JOHN (Executive)

Company: IRADIMED CORP (IRMD)

Report Date: 2026-06-20

Detailed Transactions and Holdings:

• Acquired 5,796 shares of Common Stock (Direct)
  Date: 2026-06-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 14,256.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 2,319 shares of Common Stock at $92.2 per share (Direct)
  Date: 2026-06-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 11,937.00 | transaction_form_type: 4
• Sold 5,796 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-20 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.
• F2: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on June 30, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.